# Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB

> **NCT06887023** · — · COMPLETED · sponsor: **The First Hospital of Jilin University** · enrollment: 118 (actual)

## Conditions studied

- Bile Duct Neoplasms Malignant

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06887023
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-01
- **Primary completion:** 2025-01-15
- **Final completion:** 2025-02-01
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06887023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06887023, "Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06887023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
